These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

144 related articles for article (PubMed ID: 6782251)

  • 41. Renal failure associated with the use of thio-tepa.
    Schellhammer PF
    J Urol; 1973 Nov; 110(5):498-501. PubMed ID: 4201562
    [No Abstract]   [Full Text] [Related]  

  • 42. [Spontaneously cured pancytopenia due to intravesical thio-tepa, apropos of one case].
    Archimbaud JP; Calcat P; Martel JP
    J Urol Nephrol (Paris); 1973 Dec; 79(12 Pt 2):487-8. PubMed ID: 4216648
    [No Abstract]   [Full Text] [Related]  

  • 43. Intravesical thiotepa prophylaxis of superficial bladder cancer. A follow-up study.
    Fosså SD; Miller A; Stenwig AE
    Eur Urol; 1983; 9(4):207-10. PubMed ID: 6409615
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Rationale for intensive intravesical chemotherapy for superficial bladder cancer.
    Soloway MS
    J Urol; 1980 Apr; 123(4):461-6. PubMed ID: 6767860
    [No Abstract]   [Full Text] [Related]  

  • 45. The role of cystography in thio-tepa toxicity.
    Orlin I
    J Urol; 1972 Aug; 108(2):257-8. PubMed ID: 4625850
    [No Abstract]   [Full Text] [Related]  

  • 46. The management of superficial bladder cancer.
    Soloway MS
    Cancer; 1980 Apr; 45(7 Suppl):1856-65. PubMed ID: 6768441
    [No Abstract]   [Full Text] [Related]  

  • 47. [Intravascular thio-tepa in the treatment of papillary neoplasms of the bladder].
    Furnari S; Lattuca C; Pavone-Macaluso M; Leone G
    Arch Ital Urol Nefrol; 1968; 41(3):187-98. PubMed ID: 4982415
    [No Abstract]   [Full Text] [Related]  

  • 48. Intravesical thiotepa in the treatment of transitional cell bladder carcinoma.
    Mitchell RJ
    Br J Urol; 1971 Apr; 43(2):185-8. PubMed ID: 4996214
    [No Abstract]   [Full Text] [Related]  

  • 49. Intravesical therapy comparing BCG, adriamycin, and thiotepa in 200 patients with superficial bladder cancer: a randomized prospective study.
    Martinez-Pineiro JA; Jimenez León J; Martinez-Pineiro L; Fiter L; Mosteiro JA; Navarro J; García Matres MJ; Cárcamo P
    Prog Clin Biol Res; 1989; 310():237-52. PubMed ID: 2505269
    [TBL] [Abstract][Full Text] [Related]  

  • 50. [Personal experience with thio-tepa in the treatment of papillomas and superficial carcinomas of the bladder].
    Pellet A; Djulepa J
    Ther Umsch; 1970 May; 27(5):310-3. PubMed ID: 4994886
    [No Abstract]   [Full Text] [Related]  

  • 51. [Chemoprophylaxis with intravesical thiotepa in non-infiltrating bladder tumors].
    Lancina Martín J; Monsalve Rodríguez M; Gómez Cisneros S; García Alonso J
    Arch Esp Urol; 1986 Sep; 39(7):479-83. PubMed ID: 3099658
    [No Abstract]   [Full Text] [Related]  

  • 52. Intravesical chemotherapy and chemoprevention of superficial, low grade, low stage bladder carcinoma.
    Koontz WW
    Semin Oncol; 1979 Jun; 6(2):217-9. PubMed ID: 113878
    [No Abstract]   [Full Text] [Related]  

  • 53. [Effect of thio-tepa on the microbial flora of the urine in bladder neoplasms].
    Stetsenko DV
    Urol Nefrol (Mosk); 1972; 37(6):55-6. PubMed ID: 4198610
    [No Abstract]   [Full Text] [Related]  

  • 54. [Intravesical BCG, mitomycin-C and thiotepa in the prevention of bladder tumor recurrence after operation].
    Wang SH
    Zhonghua Wai Ke Za Zhi; 1992 Jul; 30(7):410-2, 443-4. PubMed ID: 1301342
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Severe pancytopenia associated with the use of intravesical thio-TEPA.
    Watkins WE; Kozak JA; Flanagan MJ
    J Urol; 1967 Oct; 98(4):470-1. PubMed ID: 4964489
    [No Abstract]   [Full Text] [Related]  

  • 56. Use of intravesical thiotepa in superficial bladder tumours.
    Kulkarni JN; Kamat MR; Juvekar RL
    Indian J Cancer; 1981 Sep; 18(3):222-4. PubMed ID: 6796504
    [No Abstract]   [Full Text] [Related]  

  • 57. Chemoprophylaxis of bladder cancer recurrence: immunological aspects.
    Corrado F; Lalanne G; Pizza GC
    Panminerva Med; 1975; 17(7-8):253-8. PubMed ID: 808781
    [No Abstract]   [Full Text] [Related]  

  • 58. Thiotepa bladder instillations: therapy and prophylaxis for superficial bladder tumors.
    Veenema RJ; Dean AL; Uson AC; Roberts M; Longo F
    J Urol; 1969 May; 101(5):711-5. PubMed ID: 4976352
    [No Abstract]   [Full Text] [Related]  

  • 59. Topical use of Thio-Tepa for tumours of the bladder.
    Oravisto KJ
    Urol Int; 1965; 20(1):23-8. PubMed ID: 4953655
    [No Abstract]   [Full Text] [Related]  

  • 60. A trial of prophylactic thiotepa or mitomycin C intravesical therapy in patients with recurrent or multiple superficial bladder cancers.
    Flanigan RC; Ellison MF; Butler KM; Gomella LG; McRoberts JW
    J Urol; 1986 Jul; 136(1):35-7. PubMed ID: 3086575
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.